Pfizer's Q1 2023 results beat market forecasts, with strong revenue growth and cost management improvements. I think it's the turning point for PFE stock - read on.The company expects continued growth...
Source LinkPfizer's Q1 2023 results beat market forecasts, with strong revenue growth and cost management improvements. I think it's the turning point for PFE stock - read on.The company expects continued growth...
Source Link
Comments